WETOUCH TECHNOLOGY INC. (WETH)
WeTouch Secures Singapore Commercial Outdoor Project, Demonstrating Whole-Product Customization and Expanding Southeast Asia Footprint
WeTouch Secures Singapore Commercial Outdoor Project, Demonstrating Whole-Product Customization and Expanding Southeast Asia Footprint
Novo Nordisk wins Dutch court injunction protecting patients from unapproved, unlawful compounded semaglutide nasal spray
INTU INVESTOR DEADLINE: Robbins Geller Rudman & Dowd LLP Announces that Intuit Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
FitLife Brands Announces Second Quarter Earnings Call
Clinical trial NCT06903702 updates: 1. status: NOT_YET_RECRUITING → WITHDRAWN 2. enrollment: 100 → 0 participants 3. enrollment type: ESTIMATED → ACTUAL
Clinical trial NCT07742475: start date: 2026-07-01 → 2026-09-01.
Clinical trial NCT06773936: start date: 2026-05-15 → 2026-04-13.
Clinical trial NCT07294872 updates: 1. start date: 2026-05-08 → 2026-12-08 2. primary completion date: 2026-09-20 → 2027-09-20
Clinical trial NCT03952559 updates: 1. status: ACTIVE_NOT_RECRUITING → COMPLETED 2. completion date: 2026-05-01 → 2026-05-22
Clinical trial NCT06006403 updates: 1. status: RECRUITING → COMPLETED 2. start date: 2023-08-31 → 2024-03-28 3. completion date: 2026-08-31 → 2025-12-31 4. primary completion date: 2025-12-31 → 2025-09-25 5. enrollment: 36 → 5 participants 6. enrollment type: ESTIMATED → ACTUAL
Clinical trial NCT07216482 updates: 1. completion date: 2027-03-01 → 2026-11-05 2. primary completion date: 2026-12-02 → 2026-08-12
Clinical trial NCT04967833 updates: 1. completion date: 2026-04-22 → 2029-04-22 2. primary completion date: 2025-12-22 → 2027-12-22
Clinical trial NCT07177066 updates: 1. status: RECRUITING → COMPLETED 2. completion date: 2026-05-01 → 2026-04-29 3. primary completion date: 2026-05-01 → 2026-04-29 4. enrollment: 108 → 84 participants 5. enrollment type: ESTIMATED → ACTUAL
Clinical trial NCT05885139 updates: 1. status: UNKNOWN → COMPLETED 2. completion date: 2024-06-30 → 2025-12-31 3. primary completion date: 2024-06-30 → 2025-12-31 4. enrollment type: ESTIMATED → ACTUAL
Clinical trial NCT06052631: start date: 2026-08-07 → 2026-08-10.